FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Gland Pharma IPO and Likhitha Infrastructure IPO.
Gland Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Likhitha Infrastructure IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Gland Pharma IPO | Likhitha Infrastructure IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Citigroup Global Markets India Private Limited Haitong Securities India Private Limited Kotak Mahindra Capital Company Limited Nomura Financial Advisory And Securities (India) Pvt Ltd |
Unistone Capital Pvt Ltd |
Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Gland Pharma IPO is up to ₹6,479.55 Cr whereas the issue size of the Likhitha Infrastructure IPO is up to ₹61.20 Cr. The final issue price of Gland Pharma IPO is ₹1,500.00 per share and of Likhitha Infrastructure IPO is ₹120.00 per share.
Gland Pharma IPO | Likhitha Infrastructure IPO | |
---|---|---|
Face Value | ₹1 per share | ₹10 per share |
Issue Price (Lower) | ₹1,490.00 per share | ₹116.00 per share |
Issue Price (Upper) | ₹1,500.00 per share | ₹120.00 per share |
Issue Price (Final) | ₹1,500.00 per share | ₹120.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 10 shares | 125 shares |
Fresh Issue Size | 83,33,333 shares | 51,00,000 shares |
Fresh Issue Size (Amount) | up to ₹1,250.00 Cr | up to ₹61.20 Cr |
OFS Issue Size | 3,48,63,635 shares | |
OFS Issue Size (Amount) | up to ₹5,229.55 Cr | |
Issue Size Total | 4,31,96,968 shares | 51,00,000 shares |
Issue Size Total (Amount) | up to ₹6,479.55 Cr | up to ₹61.20 Cr |
Gland Pharma IPO opens on Nov 09, 2020, while Likhitha Infrastructure IPO opens on Sep 29, 2020. The closing date of Gland Pharma IPO and Likhitha Infrastructure IPO is Nov 11, 2020, and Oct 07, 2020, respectively.
Gland Pharma IPO | Likhitha Infrastructure IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Nov 09, 2020 | Sep 29, 2020 |
Issue Close | Nov 11, 2020 | Oct 07, 2020 |
Basis Of Allotment (Tentative) | Nov 17, 2020 | Oct 12, 2020 |
Initiation of Refunds (Tentative) | Nov 18, 2020 | Oct 13, 2020 |
Credit of Share (Tentative) | Nov 19, 2020 | Oct 14, 2020 |
Listing date (Tentative) | Nov 20, 2020 | Oct 15, 2020 |
Anchor Lockin End date 1 | Dec 17, 2020 | Nov 11, 2020 |
Anchor Lockin End date 2 | Feb 15, 2021 | Jan 10, 2021 |
Gland Pharma IPO P/E ratio is , as compared to Likhitha Infrastructure IPO P/E ratio of .
Gland Pharma IPO | Likhitha Infrastructure IPO | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 74% | 99.96% | |||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 58% | 74.11% | |||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||
ROE | |||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||
EPS | |||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Gland Pharma IPO retail investors (RII) are offered 1,51,18,939 shares while in Likhitha Infrastructure IPO retail investors are offered 1,51,18,939 shares. Qualified institutional buyers (QIB) are offered 86,39,394 shares in Gland Pharma IPO and 51,000 shares in Likhitha Infrastructure IPO.
Gland Pharma IPO | Likhitha Infrastructure IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 86,39,394 shares | 51,000 shares |
NII | 64,79,546 shares | 32,64,000 shares |
RII | 1,51,18,939 shares | 17,85,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 3,02,37,879 shares | 51,00,000 shares |
Gland Pharma IPO subscribed 2.06x in total, whereas Likhitha Infrastructure IPO subscribed 9.51x.
Gland Pharma IPO | Likhitha Infrastructure IPO | |
---|---|---|
QIB (times) | 6.40x | 21.99x |
NII (times) | 0.51x | 1.54x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 0.24x | 23.71x |
Employee (times) | ||
Other (times) | ||
Total (times) | 2.06x | 9.51x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|